Adam J Lordan

Adam J Lordan is an experienced healthcare professional with a robust background in business development and sales within the pharmaceutical and biotechnology sectors. Currently serving as an Area Business Specialist at Xeris Pharmaceuticals, Inc., Adam specializes in ultra-rare diseases, focusing on Primary Periodic Paralysis. Adam's previous roles include Director of Business Development at Cognetivity Neurosciences Ltd, where work centered on AI platforms for cognitive impairment detection, and Senior Territory Business Manager for Bristol-Myers Squibb in the neurology division. Other significant experience includes leadership positions at Kedrion Biopharma, IMC of New England, and Within3, where Adam has successfully driven revenue growth and established strategic partnerships. Adam holds a BA in Criminal Justice from Saint Anselm College and completed a certificate program in Public Health at the University of New Hampshire-Manchester.